Art

J-GLOBAL ID：201902249893267675   Reference number：19A0019392

Radiotherapy to the primary tumour for newly diagnosed, metastatic prostate cancer (STAMPEDE): a randomised controlled phase 3 trial

新たに診断された転移性前立腺癌(Stampede)に対する原発腫瘍への放射線療法:無作為化対照第3相試験【JST・京大機械翻訳】

Author (49)： Parker Christopher C (Academic Urology Unit, Royal Marsden Hospital, London, UK) ,  Parker Christopher C (Institute of Cancer Research, London, UK) ,  James Nicholas D (Institute of Cancer and Genomic Sciences, University of Birmingham, Birmingham, UK) ,  Brawley Christopher D (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Clarke Noel W (Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK) ,  Clarke Noel W (Department of Urology, Salford Royal Hospitals, Manchester, UK) ,  Hoyle Alex P (Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK) ,  Hoyle Alex P (Department of Urology, Salford Royal Hospitals, Manchester, UK) ,  Ali Adnan (Genito-Urinary Cancer Research Group, Department of Surgery, The Christie Hospital, Manchester, UK) ,  Ali Adnan (The FASTMAN/Genito-Urinary Cancer Research Groups, Division of Cancer Sciences, and Belfast-Manchester Movember Centre of Excellence, Manchester Cancer Research Centre, University of Manchester, Manchester, UK) ,  Ritchie Alastair W S (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Attard Gerhardt (UCL Cancer Institute, UCL, London, UK) ,  Chowdhury Simon (Department of Medical Oncology, Guy’s & St Thomas’ NHS Foundation Trust, London, UK) ,  Cross William (Department of Urology, St James University Hospital, Leeds, UK) ,  Dearnaley David P (Academic Urology Unit, Royal Marsden Hospital, London, UK) ,  Dearnaley David P (Institute of Cancer Research, London, UK) ,  Gillessen Silke (Division of Cancer Sciences, University of Manchester and the Christie, Manchester, UK) ,  Gillessen Silke (Division of Oncology and Haematology, Kantonsspital, St Gallen, Switzerland) ,  Gilson Clare (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Jones Robert J (Beatson West of Scotland Cancer Centre, University of Glasgow, Glasgow, UK) ,  Langley Ruth E (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Malik Zafar I (The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK) ,  Mason Malcolm D (Division of Cancer & Genetics, School of Medicine, Cardiff University, Cardiff, UK) ,  Matheson David (Faculty of Education, Health and Wellbeing, University of Wolverhampton, Wolverhampton, UK) ,  Millman Robin (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Russell J Martin (Institute of Cancer Sciences, University of Glasgow, Glasgow, UK) ,  Thalmann George N (Department of Urology, University Hospital, Inselspital, Bern, Switzerland) ,  Amos Claire L (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Alonzi Roberto (Mount Vernon Cancer Centre, London, UK) ,  Bahl Amit (Bristol Haematology and Oncology Centre, Bristol, UK) ,  Birtle Alison (Rosemere Cancer Centre, Lancashire Teaching Hospitals, Preston, UK) ,  Birtle Alison (School of Cancer Sciences, University of Manchester, Manchester, UK) ,  Din Omar (Department of Clinical Oncology, Weston Park Cancer Centre, Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, UK) ,  Douis Hassan (Department of Radiology, University Hospital Birmingham NHS Foundation Trust, Birmingham, UK) ,  Eswar Chinnamani (The Clatterbridge Cancer Centre NHS Foundation Trust, Liverpool, UK) ,  Gale Joanna (Portsmouth Oncology Centre, Queen Alexandra Hospital, Portsmouth, UK) ,  Gannon Melissa R (Department of Health Services Research, London School of Hygiene & Tropical Medicine, London, UK) ,  Jonnada Sai (Department of Oncology, Gloucestershire Hospitals NHS Foundation Trust, Gloucester, UK) ,  Khaksar Sara (St Luke’s Cancer Centre, Royal Surrey County Hospital, Guildford, UK) ,  Lester Jason F (Velindre Cancer Centre, Cardiff, UK) ,  O'Sullivan Joe M (Centre for Cancer Research and Cell Biology, Queen’s University Belfast, Belfast, UK) ,  Parikh Omi A (Department of Clinical Oncology, East Lancashire Hospitals NHS Trust, Blackburn, UK) ,  Pedley Ian D (Northern Centre for Cancer Care, Freeman Hospital, Newcastle upon Tyne, UK) ,  Pudney Delia M (Clinical Oncology, Singleton Hospital, Swansea, UK) ,  Sheehan Denise J (Exeter Oncology Centre, Royal Devon & Exeter Hospital, Exeter, UK) ,  Srihari Narayanan Nair (Department of Oncology, Shrewsbury and Telford Hospitals NHS Trust, Shrewsbury, UK) ,  Tran Anna T H (Department of Clinical Oncology, The Christie NHS Foundation Trust, Manchester, UK) ,  Parmar Mahesh K B (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK) ,  Sydes Matthew R (Medical Research Council (MRC) Clinical Trials Unit at University College London (UCL), London, UK)
Material： Lancet
Volume： 392  Issue： 10162  Page： 2353-2366  Publication year： 2018 
JST Material Number： B0673A  ISSN： 0140-6736  CODEN： LANCA  Document type： Article
Article type： 原著論文  Country of issue： Netherlands (NLD)  Language： ENGLISH (EN)

Abstract/Point： Based on previous findings, we...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=19A0019392&from=J-GLOBAL&jstjournalNo=B0673A") }}

Thesaurus term： man ,  Safety ,  *prostate gland ,  effect ,  *Radiotherapy ,  United Kingdom ,  prostate-specific antigen ,  *phase 3 study ,  *prostatic tumor ,  stratification ,  drug therapy ,  non-steroidal anti-inflammatory drug ,  adverse reaction ,  aromatic carboxylic acid ,  carbamate ,  oxygen heterocyclic compound ,  bridged compound ,  tetracyclic diterpene ,  carboxylate (ester) ,  hydroxy acid ,  hydroxy ketone ,  polyol
Semi thesaurus term： non-steroidal anti-inflammatory agent ,  有害事象 ,  *転移性 ,  *転移性前立腺癌 , 【Automatic Indexing@JST】

JST classification (2)： Radiotherapy for tumors  (GE03034K) ,  Drug therapy(=pharmacotherapy)for tumors  (GE03032C)

Substance index (1)： Docetaxel

Terms in the title (6)： 診断 ,  転移性前立腺癌 ,  原発腫瘍 ,  放射線療法 ,  対照 ,  第3相試験